Tesla Motors, Inc. (TSLA) was reiterated an ‘Underperform’ by BofA/Merrill (BAC) analysts on Thursday. The broker also raised its price target on the stock by 177% to $180 from $65.
TSLA shares recently gained $6.51 to $275.66. In the past 52 weeks, shares of Palo Alto, California-based electric car maker have traded between a low of $181.40 and a high of $291.42. Shares are up 12.28% year-over-year and 21.02% year-to-date.
Analysts at Compass Point are out with a report this morning upgrading shares of Xoom Corporation (XOOM) with a ‘Neutral‘ from ‘Sell‘ rating. The firm raised its price target for the company to $25 from $11.
Xoom Corp. shares have a forward P/E of 42.88 and t-12 price-to-sales ratio of 4.82. EPS for the same period is ($0.73).
In the past 52 weeks, shares of online money transfers services provider have traded between a low of $13.14 and a high of $26.94 and are now at $25.20. Shares are down 25.00% year-over-year ; up 18.22% year-to-date.
Terex Corporation (TEX) was raised to ‘Neutral‘ from ‘Underperform‘ at BofA/Merrill (BAC) on Thursday.
TEX is up $0.79 at $23.34 on normal volume. Midway through trading Thursday, 702K shares of Terex Corp. have exchanged hands as compared to its average daily volume of 2.09 million shares. The stock has ranged in a price between $22.77-$23.73 after having opened the day at $23.10 as compared to the previous trading day’s close of $22.55.
In the past 52 weeks, shares of Westport, Connecticut-based company have traded between a low of $22.01 and a high of $42.53. Shares are down 45.31% year-over-year and 18.74% year-to-date.
AstraZeneca PLC (AZN) was upgraded to ‘Buy‘ from ‘Hold‘ by Berenberg analysts on Thursday.
AZN is currently printing a normal trading volume with the issue trading 373K shares, compared to the average volume of 1.58 million. The stock began trading this morning at $65.52 to currently trade 1.45% higher from the prior days close of $64.64. On an intraday basis it has gotten as low as $65.33 and as high as $65.72.
AstraZeneca PLC ADS shares are priced at 64.74x this year’s forecasted earnings, compared to the industry’s 0.41x earnings multiple. The company’s current year and next year EPS growth estimates stand at (1.6%) and (3.1%) compared to the industry growth rates of 48.40% and 91.90%, respectively. AZN has a t-12 price-to-sales ratio of 3.18. EPS for the same period registers at $1.01.
AstraZeneca shares have declined 3.52% in the last 4 weeks and 6.03% in the past three months. Over the past 5 trading sessions the stock has lost 2.84%.
The London-based firm, which is currently valued at $82.89 billion, has a median Wall Street price target of $72.94 with a high target of $98.57. AstraZeneca PLC ADS is down 9.99% year-over-year, compared with a 4.63% gain in the S&P 500.
In a report published Thursday, Sidoti analysts initiated coverage on Lattice Semiconductor Corporation (LSCC) with a ‘Buy‘ rating and $11 price target.
On valuation measures, Lattice Semiconductor Corp. shares currently have a PEG and forward P/E ratio of 0.88 and 8.71, respectively. Price/sales for the same period is 1.89 while EPS is ($0.15). Currently there are 4 analysts that rate LSCC a ‘Buy’ versus no analysts rating it a ‘Sell’. LSCC has a median Wall Street price target of $8.50 with a high target of $10.00.